|国家科技期刊平台
首页|期刊导航|西安交通大学学报(医学版)|消融术在甲状腺肿瘤应用中的是与非

消融术在甲状腺肿瘤应用中的是与非OACSTPCD

The rights and wrongs of ablation in treating thyroid tumors

中文摘要英文摘要

结合相关指南及专家共识,对消融术在甲状腺肿瘤中的应用现状进行总结.消融术在甲状腺良性肿瘤中的应用近年来逐渐成熟,而在甲状腺恶性肿瘤中的应用存在较大争议,已有部分临床实践正不断尝试拓宽消融术在甲状腺恶性肿瘤方面的应用范围.目前消融术主要适用于甲状腺良性肿瘤,预后良好且患者满意度高.由于该技术无法避免甲状腺恶性肿瘤潜在的复发风险及根除局部或远处隐匿性转移,故应用于甲状腺恶性肿瘤时应严格把握适应证.

This article summarizes the current status of the application of ablation in thyroid tumors with reference to relevant guidelines and expert consensus.The application of ablation in treating benign thyroid tumors has gradually gained maturity in recent years,but the application in malignant thyroid tumors is controversial.Currently,some clinical practices are constantly trying to broaden the application of ablation in treating malignant thyroid tumors.Ablation,which is mainly applied to benign thyroid tumors,has good prognosis and high patient satisfaction.Since this technique cannot avoid the potential recurrence risk of malignant thyroid tumors or eradicate local or distant occult metastases,the indications for the use of ablation in malignant thyroid tumors should be strictly controlled.

殷德涛;乔立雪

郑州大学第一附属医院甲状腺外科,河南省甲状腺癌多学科诊疗工程研究中心,河南省甲状腺癌医学重点实验室,河南郑州 450052

临床医学

甲状腺肿瘤消融术应用现状

thyroid tumorablationapplication status

《西安交通大学学报(医学版)》 2024 (001)

39-43 / 5

河南省自然科学基金面上项目(No.222300420568);河南省医学科技攻关重大计划项目(No.SBGJ202101014);河南省中医药研究重大专项(No.20-21ZYZD14);河南省中青年医学科技创新领军人才项目(No.YXKC2020015)Supported by General Project of Natural Science Foundation of Henan Province(No.222300420568),Key Medical Science and Tech-nology Project of Henan Province(No.SBGJ202101014),Major Scientific Research Projects of Traditional Chinese Medicine in Henan Province(No.20-21ZYZD14),and Cultivation of Young and Middle-aged Health Science and Technology Innovation Leading Talents in Henan Province(No.YXKC2020015)

10.7652/jdyxb202401007

评论